vTv Therapeutics to Present at the Rodman & Renshaw Global Investment Conference
08 September 2016 - 9:00PM
Business Wire
vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical-stage
biopharmaceutical company engaged in the discovery and development
of new orally administered treatments for Alzheimer’s disease and
diabetes, today announced that Company management will present
a corporate overview at the Rodman & Renshaw Global Investment
Conference, sponsored by H.C. Wainwright & Co., LLC. The
company’s management will be presenting in the Holmes I room from
9:35 to 10:00am on September 12.
A live webcast of the presentation can be accessed on
the News & Events section of the website. The
webcast will be archived for 30 days following the presentation on
the company website at www.vtvtherapeutics.com.
About vTv Therapeutics
vTv Therapeutics Inc. is a clinical-stage biopharmaceutical
company engaged in the discovery and development of orally
administered small molecule drug candidates to fill significant
unmet medical needs. vTv has a pipeline of clinical drug candidates
led by programs for the treatment of Alzheimer’s disease and Type 2
diabetes as well as treatment of inflammatory disorders and the
prevention of muscle weakness.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160908005310/en/
Media:vTv TherapeuticsNura Strong, 336-841-0300
X164nstrong@vTvTherapeutics.com
vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From Apr 2024 to May 2024
vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From May 2023 to May 2024